Cited by — Pathological Response and Survival Outcomes Following Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer: Real-world Experience | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Pathological Response and Survival Outcomes Following Neoadjuvant Chemotherapy in HR+/HER2- Breast Cancer: Real-world Experience.
No admitted local citation edges point to this work yet.
